tirzepatide and alcohol reduction Study found that the weight loss drug, reduces consumption prevents relapse behaviors in rodents. These results suggest that medications targeting the body's metabolic hormones could eventually become an option Tirzepatide and Hot Flashes: Causes,

SGLT2 vs Dual Agonists: Putting Weight Loss in Context SGLT2 inhibitors like empagliflozin (Jardiance) offer modest weight reduction of approximately 4 to 6 pounds, a fraction of what dual agonists deliver

Tirzepatide is a medication, made by Eli Lilly, that treats diabetes, obesity, and sleep apnea

Switching between GLP-1 receptor agonists in clinical practice: expert consensus and practical guidance

But even on tirzepatide alone, drinking on an empty stomach, which many people do because the medication suppresses appetite , creates the perfect setup for a blood sugar crash

Beckers lab is addressing that gap by mapping where these drugs act in the brain and how they influence reward and motivation circuits, including how signals from the gut may shape craving and behavior